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This issue begins with two commentary pieces. Our initial commentary concerns the question of whether integrative therapies may contribute to the lowering of health care costs. We base this commentary on a thought experiment, in which we use some basic data on cost-effectiveness gleaned from literature review, extrapolated to the national level. The results of our experiment were intriguing, and tie into other debates about the cost-effectiveness of preventive therapies as well as throwing light on how even simple integrative interventions may have major financial impacts.
A second commentary by Ralph Muecke of the Klinikum Lippe and his colleagues concerns the use of selenium in cancer patients. Although the preventive use of selenium is still a matter of some debate, data from a recent randomized trial on the use of sodium selenite in gynecological cancer patients going through radiation therapy suggest that supplementing tumor patients may provide some distinct advantages. Selenium has a key role in cellular antioxidant levels, but no evidence of tumor protection was reported from this trial. Muecke and colleagues also emphasize the need to test patients for selenium levels to avoid further supplementation of those who already have normal levels. Testing before supplementation is a clinical strategy that I certainly endorse, and it is welcome to see this analysis of the reasons behind such testing.
A systematic review of data on quality-of-life results of randomized and non-randomized trials of mistletoe therapy by Gunver and Helmut Kienle of the Institute for Applied Epistemology and Medical Methodology initiates our regular articles for this issue. The institute is in Freiburg, Germany, and has already produced several reviews on aspects of anthroposophic medicine, of which mistletoe therapy is one dimension. Half of the studies in this review were of mistletoe given along with conventional treatments-surgery, radiation therapy, or chemotherapy. All but one of the studies with higher methodological quality reported better quality of life with mistletoe therapy. Fatigue was an outcome of particular significance and deserving of further study. Given the profound effects of cancer-related fatigue, this is a very interesting finding.
Elizabeth Dean-Clower and colleagues at the Dana-Farber Cancer Institute's Leonard P. Zakim Center for Integrative Therapies have contributed an article on acupuncture as palliative therapy for symptoms in advanced cancer patients. This pilot trial involved patients with advanced breast or ovarian cancer. Highly significant improvements in anxiety, depression, fatigue, and pain were observed, suggesting the feasibility of further trials in this time-honored therapy. We certainly hope to see such trials carried forward.
Following the acupuncture contribution, we have two articles on the very important topic of communication with cancer patients about use of complementary and alternative medicine (CAM). An observational study of taped interactions between oncologists and breast cancer patients has been contributed by Ilona Juraskova at the Centre for Medical Psychology and Evidence-Based Decision Making at the University of Sydney in Australia. These authors reported mostly encouraging responses to patients who brought up questions about use of CAM, but it was very clear that doctors needed further education about CAM therapies and guidance on how to effectively discuss use of CAM, taking into account both safety issues and respect for patients' beliefs. We would add that it is important for physicians to receive education about the emerging data on effective CAM therapies and how they can be applied in the clinic.
Moshe Frenkel and colleagues at M.D. Anderson Cancer Center and Haifa and Western Galilee Oncology Service may provide some of the guidance the previous article seeks on ways to communicate effectively in the area of CAM and cancer (with application to other fields of medicine as well). These authors elaborate on the need for fostering a collaborative relationship with patients that includes information exchange, responding to emotional needs and managing uncertainty. Their model is based on a comprehensive literature review, and elucidates principles of communication that we feel may prove extremely useful in medical education.
Following these clinically based studies, we turn our attention to the laboratory, starting with two studies on supplements aimed at prostate cancer, both produced by Jun Yan and Aaron Katz of Columbia University. Conventionally based physicians, and many in the area of CAM, frequently find it disturbing when supplements contain multiple chemical entities and herbs, although multicomponent formulas are definitely the prototype of the traditional herbal remedies of China, India, and other cultures. The first of the articles by Yan and Katz concerns a multicomponent formula, ProstaCaid. The authors demonstrate definite effects on cell cycle arrest and apoptosis of this formula. Not surprisingly, it has a number of modes of action, including effects on cyclins, p21, caspases, AKT, and MAPK signaling as well as other effects. Their second article concerns the single component formula PectaSol, a modified citrus pectin. Cytotoxic effects on five cell lines as well as pro-apoptotic effects were demonstrated for this formula. Modified citrus pectin has been of interest in prostate cancer for quite some time, so it is particularly interesting to see this detailed mechanistic analysis demonstrate its potential for chemoprevention and chemotherapy of prostate cancer.
Red yeast rice is the original source of the statin drugs, based on the molecule monacolin (lovastatin), one of its constituents. This natural product, sold as a dietary supplement for cardiovascular health in the United States, is produced by the fermentation of rice with a fungus from the genus Monascus. Statins are currently of major interest in cancer prevention. An article by Ho Bing of the National Taiwan University Hospital and colleagues examines the effects of red yeast rice (also called red mold rice) on angiogenesis and metastasis in colorectal cancer cell lines. They report substantial inhibition of neovascularization as well as inhibition of matrix metalloproteinases with a red yeast rice extract in a very relevant and intriguing contribution to the literature of statins and cancer.
Sophora japonica, also known as Styphnolobium japonicum, is called the Scholar Tree or Pagoda Tree. It is one of the "50 fundamental herbs" of traditional Chinese medicine. Its constituent oxymatrine has been examined by Yanwei Li and colleagues. High doses of this compound inhibit the development of tolerance to morphine, a drug of paramount importance in control of cancer pain. Morphine tolerance results in administration of higher dosages, with concomitant increases in side effects. Oxymatrine has been shown to inhibit the development of morphine tolerance, and it retards the expression of the P-glycoprotein molecular "pump" that excretes a variety of medications out of the cell wall. However, intriguingly, Li and colleagues report data that suggest this effect may not be fully responsible for oxymatrine's enhancement of morphine's analgesic effect.
Seyed Hosseinimehr of Mazandaran University of Medical Sciences in Iran has contributed an article on the chemoprotective effect of the herb Zataria multiflora. Of particular interest is the finding that the herbal extract inhibited bone marrow suppression induced by the antitumor agent cyclophosphamide. This indicates its potential for use as an adjunct to chemotherapy, which should now be explored further in animal trials. K. A. Manu and Girija Kuttan of the Amala Cancer Research Institute in Kerala, India, explore the antiangiogenic activity of ursolic acid in their contribution in this issue. Ursolic acid is known to have anticancer effects, and is found in apple peels and a number of other fruits as well. Manu and Kuttan demonstrate the activity of this compound in inhibition of endothelial cell migration and invasion, and in the inhibition of matrix metalloproteinases. Because ursolic acid is well tolerated orally and topically, this is a finding of considerable interest.
Our final article is an Integrative Tumor Board contributed by Hyo-Min Park, Hwa-Seung Yoo and colleagues at the East-West Cancer Center of Daejon University in South Korea. This Tumor Board concerns a stage-4 lung cancer patient, and the variety of treatments she is offered as part of the Wheel Balance Cancer Therapy version of traditional Korean medicine. Both lifestyle and herbal medicine treatments are offered at the East-West Center. One of the most interesting therapies at this center is hiking in the nearby forests, an activity very well regarded by patients, and one that would, I'm certain, be healthful and pleasant for many of this journal's readers, especially those of us in the Northern Hemisphere who are now at the start of our summer season.
